Center for Pharmacoeconomic Research

Recent Publications

Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D.   Evaluating equivalency between response systems: Application of the Rasch Model to a 3-Level and 5-Level EQ-5D. Medical Care. 2007; 45(9):812-819.

Dobrez D, Cella D, Pickard AS, Lai JS, Nickolov A.  Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general.  Value in Health. 2007;10(4):266-72.

Hung SY, Pickard AS, Witt WP, Lambert BL.  Pain and depression in caregivers affected their perception of pain in stroke patients. Journal of Clinical Epidemiology. 2007;60(9):963-70.

Schumock G, Arruda J, Marx S, Melnick J, Sterz R, Williams L. Cost-effectiveness of paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Journal of Medical Economics (in press)

Touchette DR, Masica A. Evidence needed for policy decisions: adherence interventions and Medicare Part D (Letter). Arch Intern Med. 2007;167(17):1905.

Touchette DR, McGuinness ME, Stoner S, Shute D, Edwards JM, Ketchum KL.
Improving Antithrombotic Therapy for Hospitalized Patients with Atrial Fibrillation. Pharmacy Practice. (in press)

Lee TA, Pickard AS.  Azelastine for allergic rhinitis: a meta-analysis.   Pharmacotherapy.  2007;27(6):852-9. 

Lee TA, Pickard AS, Bartle B, Weiss K.  Osteoarthritis: A co-morbid marker for longer life?  Ann Epidemiology.  2007;17(5):380-384.

Pickard AS, Wilke C, Lin HW, Lloyd A.  EQ-5D health utilities in studies of cancer:    Pharmacoeconomics. 2007;25(5):365-384

Pickard AS, Dalal MR, Bushnell D.  A comparison of depressive symptoms in stroke and primary care: applying Rasch models to evaluate the CES-D scale. Value in Health 2006;9(1):59-64.

Pickard AS, Dobrez D, Cella D.  Empirically testing assumptions underlying the development of a set of societal weights for the FACT-L.  Pharmacoeconomics 2006;24(3):293-4.

Pickard AS, Hung S-Y.  An update on evidence of clinical pharmacy services' impact on health-related quality of life. Annals of Pharmacotherapy 2006;40(9):1623-34.

Rosen RC, Shaw JW. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations. International journal of impotence research 2006; 18(6): 570-1.

Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of Medication Therapy Management Programs Under Medicare Part D. Journal of the American Pharmaceutical Association 2006; 46: 683-691.

Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard AS, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL.  Relation between literacy, race, and PSA level among men with newly diagnosed prostate cancer.  Urology 2006; 68:89-93.

Young WB, Shaw JW. Association between migraine and cardiovascular disease in women. JAMA 2006; 296(22): 2677.

Bennett C, Nebeker J, Lyons E, Samore M, Feldman M, McKoy J, Carson K, Belnap S, Trifilio S, Schumock G, Yarnold P, Davidson C, Evens A, Kuzel T, Parada J, Cournoyer D, West D, Sartor O, Tallman M, Raisch D. The research on adverse drug events and reports (RADAR) project. JAMA 2005; 293(17)2131-40.

Calhoun R, Schumock G, McKoy J, Pickard S, Fitzner K, Heckinger E, Powell E, McCaffrey K, Bennet C. Granulocyte colony-stimulating factor for chemotherapy-induced netropenia in patients with small cell lung cancer: the 40% rule revisited. Pharmacoeconomics 2005; 23(8)767-75.

Hartung D, Hunt J, Siemienczuk J, Miller H, Touchette D. Clinical Implications of Accurate Problem List Entry on Heart Failure Treatment. Journal of General Internal Medicine 2005; 20(2):143-147.

Hartung D, Touchette D, Bultemeier N, Haxby D. Risk of Hospitalization for heart failure associated with the use of thiazolidinediones: a Medicaid claims based case-control study. Pharmacotherapy 2005; 25(10):1329-1336.

Hatoum H, Keye R, Marrs R, Walton S, Marshall D. A Markov Model of the Cost Effectiveness of Human-Derived FSH Versus Follitropin-β Using Comparative Clinical Trial Data. Infertility and Sterility 2005; 83(3): 804-807.

Hatoum HT, Lin SJ, Arcona S, Thomas SK, Koumaras B, Mirski D. The Use of the Occupational Disruptiveness Scale of the Neuropsychiatric Inventory-Nursing Home Version to measure the impact of Rivastigmine on the disruptive behavior of nursing home residents with Alzheimer’s disease. Journal of the American Medical Directors Association 2005; 6:238-45

Knapp K, Quist R, Walton S, Miller L. Update on the Pharmacist Shortage: National and State Data through 2003, American Journal of Health-System Pharmacy 2005; 62:492-499.

Ko Y, Lin SJ, Salmon JW, Bron MS. The impact of urinary incontinence on quality of life of the elderly. American Journal of Managed Care 2005; 11 (4): S103-S111

Kramer KM, Bennett CL, Pickard AS, Lyons EA, Wolf MS, McKoy JM, Knight SJ.  Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clinical Prostate Cancer 2005 Jun;4(1):15-23.

Lambert L, Lin SJ, Tan HK. Designing safe drug names. Drug Safety 2005; 28:495-512

Lin SJ, Crawford SY, Lurvey PL. Trend and area variation in amphetamine usage among children and adolescents in Michigan. Social Science & Medicine 2005; 60:617-626

Lin SJ, Crawford SY, Salmon JW. Revealed and potential accessibility to opioid in Michigan. Social Science & Medicine 2005; 60:1881-1891

McCarthy M Jr, Chang CH, Pickard AS, Giobbie-Hurder A, Price DD, Jonasson O, Gibbs J, Fitzgibbons R, Neumayer L.  Visual analog scales for assessing surgical pain. Journal of the American College of Surgeons 2005 Aug;201(2):245-52.

McCarthy M Jr, Chang CH, Pickard AS, Giobbie-Hurder A, Price DD, Jonasson O, Gibbs J, Fitzgibbons R, Neumayer L.  Visual analog scales for assessing surgical pain. Journal of the American College of Surgeons 2005 Aug;201(2):245-52.

McKoy J, Lyons E, Obadina E, Carson K, Pickard S, Schellhammer P, Mcleod D, Boyd C, McWilliams N, Sartor O, Schumock G, McCaffrey K, Bennett C. Caveat Medicus: Consequences of Prostate Cancer pharmaceutical suppliers pleading guilty to marketing violations and settling without admission of guilt to allegations of Medicare fraud. Journal of Clinical Oncology 2005; 23(34):8894-8905.

Park HY, Schumock GT. Overview of Outcomes Research. In: Schumock G, Brundage D, Chessman K, Dunsworth T, Fagan S, Kelly W, Rathburn R, Richie D, Semla T, Vasquez E, Zarowitz B, eds. Book 5: Science and Practice of Pharmacotherapy I,II. Pharmacotherapy Self-Assessment Program. Fifth Edition. Kansas City: American College of Clinical Pharmacy; 2005.

Pickard AS, Hung S, McKoy J, Witt W, Arseven A, Sharifi R, Wu Z, Knight S, McWilliams N, Utukari S, Schumock G, Bennett C. Opportunities for disease state management in prostate cancer. Disease Management 2005; 8(4)235-44.

Pickard AS, Johnson JA, Feeny DH.  Responsiveness of the SF-36, HUI and EQ-5D in stroke. Quality of Life Research  2005;14:207-219.

Pickard AS, Knight S.  A conceptual framework for understanding differences in proxy perspectives.  Medical Care 2005 May; 43(5):493-499.

Pickard AS, Wang Z, Walton S, Lee T. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health and Quality of Life Outcomes 2005; 3:11.

Stubbings JA, Kliethermes M, Schumock G. Medicare Drug Cards: Where’s the savings? Journal of the American Pharmacists Association 45(3), 308-9, May/June 2005.

Walton S, Graves P, Sexton R. New entry and the rate of return to education: the case of registered nurses. Atlantic Economic Journal 2005; 33:325-336.

Wolf M, Fitzner K, Powell EF, McCaffrey K, Pickard AS, McKoy J, Lindenberg G, Schumock G, Carson K, Ferreira M, Dolan N, Bennett C. Cost and cost-effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. Journal of Clinical Oncology 2005; 23(34):8877-8883.